Foghorn’s $110M of­fer­ing; Novo­vax in­vestor with­draws proxy cam­paign

Plus, news about En­deav­or Bio­sciences, Vi­core, Ar­row­head and Apri­noia Ther­a­peu­tics:

Foghorn prices $110M of­fer­ing: The Cam­bridge, MA-based biotech priced the of­fer­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER